DK1676579T3 - Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea - Google Patents

Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea

Info

Publication number
DK1676579T3
DK1676579T3 DK06004523T DK06004523T DK1676579T3 DK 1676579 T3 DK1676579 T3 DK 1676579T3 DK 06004523 T DK06004523 T DK 06004523T DK 06004523 T DK06004523 T DK 06004523T DK 1676579 T3 DK1676579 T3 DK 1676579T3
Authority
DK
Denmark
Prior art keywords
treatment
sub
tetracycline
ocular rosacea
cmt
Prior art date
Application number
DK06004523T
Other languages
Danish (da)
English (en)
Inventor
Stephen C Pflugfelder
Balakrishna L Lokeshwar
Marie Selzer
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Application granted granted Critical
Publication of DK1676579T3 publication Critical patent/DK1676579T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK06004523T 1998-05-08 1999-05-07 Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea DK1676579T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8487398P 1998-05-08 1998-05-08
PCT/US1999/009965 WO1999058131A1 (en) 1998-05-08 1999-05-07 Use of tetracyclines for treating meibomian gland disease

Publications (1)

Publication Number Publication Date
DK1676579T3 true DK1676579T3 (da) 2009-03-16

Family

ID=22187748

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06004523T DK1676579T3 (da) 1998-05-08 1999-05-07 Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea
DK99921754T DK1075265T3 (da) 1998-05-08 1999-05-07 Anvendelse af tetracycliner til behandling af sygdom i de Meibomske kirtler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK99921754T DK1075265T3 (da) 1998-05-08 1999-05-07 Anvendelse af tetracycliner til behandling af sygdom i de Meibomske kirtler

Country Status (12)

Country Link
US (6) US6455583B1 (enExample)
EP (2) EP1075265B1 (enExample)
JP (1) JP4860038B2 (enExample)
AT (2) ATE418989T1 (enExample)
AU (1) AU763164B2 (enExample)
CA (1) CA2331257C (enExample)
DE (2) DE69940227D1 (enExample)
DK (2) DK1676579T3 (enExample)
ES (2) ES2320579T3 (enExample)
PT (2) PT1676579E (enExample)
TW (2) TWI255714B (enExample)
WO (1) WO1999058131A1 (enExample)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU763164B2 (en) * 1998-05-08 2003-07-17 University Of Miami Use of tetracyclines for treating meibomian gland disease
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
EP1171163A1 (en) * 1999-04-27 2002-01-16 Antibody Systems, Inc. Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
US20040115261A1 (en) * 2001-04-05 2004-06-17 Ashley Robert A. Controlled delivery of tetracycline compounds and tetracycline derivatives
EP2332547A1 (en) * 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of inflammatory bowel disease
US20030073068A1 (en) * 2001-10-15 2003-04-17 Campbell Robert Edward Methods for application of tear-based biomarkers to ophthalmic product evaluation and clinical study management
US8192749B2 (en) * 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
WO2003088906A2 (en) * 2002-04-16 2003-10-30 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
EP1501490A2 (en) * 2002-05-06 2005-02-02 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating mucositis and fungal infection
EP1591110B1 (en) * 2003-01-22 2015-03-18 Senju Pharmaceutical Co., Ltd. Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
WO2004091483A2 (en) * 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
WO2005011707A1 (en) * 2003-07-25 2005-02-10 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
WO2007024972A2 (en) * 2005-08-22 2007-03-01 Quick-Med Technologies, Inc. Non-leaching absorbent wound dressing
CN100340241C (zh) * 2004-06-28 2007-10-03 中山大学中山眼科中心 一种滴眼液及其制备方法与用途
WO2006078925A2 (en) * 2005-01-21 2006-07-27 Warner Chilcott Company, Inc. A tetracycline metal complex in a solid dosage form
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20090043365A1 (en) * 2005-07-18 2009-02-12 Kolis Scientific, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
WO2008024100A2 (en) 2006-08-21 2008-02-28 Tearscience, Inc. Method and apparatus for treating gland dysfunction
US20070060988A1 (en) * 2005-07-18 2007-03-15 Grenon Stephen M Melting meibomian gland obstructions
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
US8950405B2 (en) * 2006-05-15 2015-02-10 Tearscience, Inc. Treatment of obstructive disorders of the eye or eyelid
US7981146B2 (en) 2006-05-15 2011-07-19 Tearscience Inc. Inner eyelid treatment for treating meibomian gland dysfunction
US7981095B2 (en) 2005-07-18 2011-07-19 Tearscience, Inc. Methods for treating meibomian gland dysfunction employing fluid jet
US8915253B2 (en) 2005-07-18 2014-12-23 Tearscience, Inc. Method and apparatus for treating gland dysfunction employing heated medium
US8255039B2 (en) 2006-09-29 2012-08-28 Tearscience, Inc. Meibomian gland illuminating and imaging
WO2013003594A2 (en) 2011-06-28 2013-01-03 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
US20080114423A1 (en) * 2006-05-15 2008-05-15 Grenon Stephen M Apparatus for inner eyelid treatment of meibomian gland dysfunction
US8128673B2 (en) * 2006-05-15 2012-03-06 Tearscience, Inc. System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US9314369B2 (en) 2006-05-15 2016-04-19 Tearscience, Inc. System for inner eyelid treatment of meibomian gland dysfunction
US8128674B2 (en) * 2006-05-15 2012-03-06 Tearscience, Inc. System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US7976573B2 (en) 2006-05-15 2011-07-12 Tearscience, Inc. Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US7981147B2 (en) 2006-05-15 2011-07-19 Tearscience, Inc. Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8137390B2 (en) 2006-05-15 2012-03-20 Tearscience, Inc. System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction
US8007524B2 (en) 2006-05-15 2011-08-30 Tearscience, Inc. Heat treatment and heat loss reduction for treating meibomian gland dysfunction
WO2008027069A1 (en) * 2006-08-21 2008-03-06 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction employing fluid
US8249695B2 (en) 2006-09-29 2012-08-21 Tearscience, Inc. Meibomian gland imaging
WO2008089327A1 (en) 2007-01-17 2008-07-24 Tearscience, Inc. Methods, systems, and apparatuses for heat treatment for treating meibomian gland dysfunction
WO2008097851A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tetracycline compositions for topical administration
WO2008097850A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tretracycline compositions for topical administration
US20080312194A1 (en) * 2007-02-28 2008-12-18 Ousler Iii George W Methods and compositions for normalizing meibomian gland secretions
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
AU2008289552B2 (en) * 2007-08-16 2014-10-09 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
USD613408S1 (en) 2008-02-06 2010-04-06 Tearscience, Inc. Eye treatment head gear
USD617443S1 (en) 2008-02-06 2010-06-08 Tearscience, Inc. Eye treatment goggles
USD614303S1 (en) 2008-02-06 2010-04-20 Tearscience, Inc. Eye treatment apparatus
JP2011515494A (ja) * 2008-03-26 2011-05-19 エリック ドネンフェルド， テトラサイクリンファミリー抗生物質を用いる、眼瞼縁および涙液膜機能の改善ならびに眼瞼縁疾患の処置のための方法
EP2313103B1 (en) * 2008-07-10 2014-06-18 Inspire Pharmaceuticals, Inc. Method of treating blepharitis
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
WO2010085572A1 (en) * 2009-01-23 2010-07-29 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with azithromycin
EP2413699B1 (en) 2009-04-01 2019-11-20 Tearscience, Inc. Ocular surface interferometry (osi) apparatus for imaging an ocular tear film
USD638128S1 (en) 2009-10-06 2011-05-17 Tearscience, Inc. Ocular device design
US8721572B1 (en) 2010-06-10 2014-05-13 Eyedetec Medical, Inc. Systems, devices, kits and methods for therapy of the eye
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US9636355B2 (en) 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
UA109359C2 (xx) * 2011-11-10 2015-08-10 Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном
WO2013126599A1 (en) * 2012-02-21 2013-08-29 Massachusetts Eye & Ear Infirmary Meibomian gland dysfunction
WO2014005138A1 (en) * 2012-06-29 2014-01-03 Kerschensteiner Daniel A Colorimetric gelatinase assay
US10842670B2 (en) 2012-08-22 2020-11-24 Johnson & Johnson Vision Care, Inc. Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices
PT106679B (pt) * 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
ES2821002T3 (es) 2013-04-30 2021-04-23 Alcon Inc Sistemas para el tratamiento de enfermedades del ojo
US9763827B2 (en) 2013-04-30 2017-09-19 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
CN105792729B (zh) 2013-05-03 2018-04-27 眼泪科学公司 用于对睑板腺进行成像以供睑板腺分析的眼睑照明系统和方法
US10130507B2 (en) 2013-08-03 2018-11-20 Michael C. Whitehurst Dry eye treatment device
WO2016022066A1 (en) * 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
WO2016079590A1 (en) 2014-11-19 2016-05-26 Dr. Reddy's Laboratories Ltd. Modified release doxycycline composition
EP3273940B1 (en) 2015-03-23 2020-12-16 Biopharmx, Inc. Pharmaceutical tetracycline composition for dermatological use
EP3178463A1 (de) 2015-12-07 2017-06-14 WDT-Wolz-Dental-Technik GmbH Verfahren zur herstellung eines keramischen körpers, insbesondere eines dentalkeramikrohlings, mit räumlich gezielt einstellbaren ausprägungsgraden physikalischer eigenschaften
US10974063B2 (en) 2016-06-30 2021-04-13 Alcon Inc. Light therapy for eyelash growth
US10667951B2 (en) 2016-08-29 2020-06-02 Nicole Kyongnan Renaud Eye mask
FR3064482B1 (fr) * 2017-04-03 2020-11-13 Horus Pharma Composition topique de doxycycline
KR20200111177A (ko) 2017-12-15 2020-09-28 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
JP2025523655A (ja) * 2022-07-08 2025-07-23 アイシーエム（インスティテュート ドゥ セルヴォ エ デ ラ ムワル エピイエレ） テトラサイクリン誘導体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788479A (fr) * 1971-09-06 1973-01-02 Medimpex Gyogyszerkulkereskede Complexes du tris(hydroxymethyl)aminomethane avec les tetracyclines formant des solutions neutres, stables, tres actives etnon toxiques
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US4866049A (en) * 1987-08-10 1989-09-12 Spectra Pharmaceutical Services, Inc. Ophthalmic compositionn and method of using same
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
FR2660193B1 (fr) * 1990-04-03 1994-11-04 Philippe Maincent Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5523297A (en) * 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US6015803A (en) * 1998-05-04 2000-01-18 Wirostko; Emil Antibiotic treatment of age-related macular degeneration
AU763164B2 (en) * 1998-05-08 2003-07-17 University Of Miami Use of tetracyclines for treating meibomian gland disease
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease

Also Published As

Publication number Publication date
DK1075265T3 (da) 2006-06-26
TW200526232A (en) 2005-08-16
US20060154901A1 (en) 2006-07-13
US6455583B1 (en) 2002-09-24
JP4860038B2 (ja) 2012-01-25
JP2002514602A (ja) 2002-05-21
US20080214510A1 (en) 2008-09-04
TWI255713B (en) 2006-06-01
PT1676579E (pt) 2009-03-24
US20030114426A1 (en) 2003-06-19
DE69930252T2 (de) 2006-12-14
EP1676579A3 (en) 2006-07-12
DE69930252D1 (de) 2006-05-04
EP1676579A2 (en) 2006-07-05
EP1676579B1 (en) 2008-12-31
ES2320579T3 (es) 2009-05-25
AU3887999A (en) 1999-11-29
AU763164B2 (en) 2003-07-17
US20110039805A1 (en) 2011-02-17
WO1999058131A1 (en) 1999-11-18
EP1075265A1 (en) 2001-02-14
ATE418989T1 (de) 2009-01-15
CA2331257C (en) 2012-01-03
HK1034899A1 (en) 2001-11-09
ES2260912T3 (es) 2006-11-01
CA2331257A1 (en) 1999-11-18
ATE319456T1 (de) 2006-03-15
DE69940227D1 (de) 2009-02-12
EP1075265B1 (en) 2006-03-08
HK1089696A1 (en) 2006-12-08
TWI255714B (en) 2006-06-01
PT1075265E (pt) 2006-07-31
US20120088739A1 (en) 2012-04-12

Similar Documents

Publication Publication Date Title
DK1676579T3 (da) Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea
ES2193901T1 (es) Derivados de prostaglandina para el tratamiento de glaucoma o hipertension ocular.
DK0801564T3 (da) Anvendelse af nebivolol som et antiatherogent middel
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
DK1514548T3 (da) Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension
BR0209468A (pt) Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar
PT998287E (pt) Utilizacao de levobupivacaina
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
DE68918099D1 (de) Pharmazeutische behandlung einer augenentwicklung.
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
DK0781560T3 (da) Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse
DE60128100D1 (de) Analgetisches arzneimittel
RU94014833A (ru) Средство для лечения дегенеративных заболеваний суставов и околосуставных тканей
WO2002017917A8 (en) Manzamines for treatment of drug resistant infection
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
BR0205932A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma
SE9602262D0 (sv) New use of derivatives of cystine
ATE289817T1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
BR0315754A (pt) Duloxetina, uso da mesma, e, composição farmacêutica
SE9900438D0 (sv) The pharmacological use of certian cystine derivatives
NO974941L (no) Ny anvendelse av (S)-adenosyl-L-metionin(SAMe)